NASDAQ | ETF
The fund is an actively-managed exchange-traded fund ("ETF") that pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes in common stocks, convertible securities, warrants and other equity securities having the characteristics of common stocks ofU. S. and foreign companies engaged in medical research, pharmaceutical and medical technology industries and related technology industries.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 15.44% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 9.05% |
| NVS | Novartis AG ADR | Healthcare | Drug Manufacturers - General | 6.76% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 6.22% |
| AZN | AstraZeneca PLC ADR | Healthcare | Drug Manufacturers - General | 5.12% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 4.91% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 4.55% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 4.26% |
| CRSP | Crispr Therapeutics AG | Healthcare | Biotechnology | 3.76% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.67% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 3.65% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 3.24% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 3.21% |
| GSK | GlaxoSmithKline PLC ADR | Healthcare | Drug Manufacturers - General | 2.54% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 2.47% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.46% |
| GALT | Galectin Therapeutics Inc | Healthcare | Biotechnology | 1.15% |
| BEAM | Beam Therapeutics Inc | Healthcare | Biotechnology | 1.10% |
| NTLA | Intellia Therapeutics Inc | Healthcare | Biotechnology | 1.04% |
| LTRN | Lantern Pharma Inc | Healthcare | Biotechnology | 0.92% |